| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
96 |
94 |
$78K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,511 |
1,448 |
$73K |
| 92134 |
|
1,935 |
1,917 |
$39K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
887 |
877 |
$36K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
386 |
374 |
$13K |
| J9035 |
Injection, bevacizumab, 10 mg |
179 |
171 |
$10K |
| 92250 |
|
156 |
156 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28 |
28 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
27 |
27 |
$2K |